News
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
2d
Health on MSNTaking Weight Loss Drugs With Type 1 Diabetes Could Come With Hidden Risks, Doctors WarnFact checked by Nick Blackmer More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study ...
Shivani Agarwal, MD, MPH, Director of the SEAD program, Fleischer Institute for Diabetes and Metabolism, Montefiore Einstein Young adults with type 1 diabetes face many challenges as they ...
A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
A misdiagnosis can happen for adults who are diagnosed with type 1, known as latent autoimmune diabetes of adults (LADA) — sometimes referred to as type 1.5 diabetes. Some research estimates ...
Both adults and children with type 1 diabetes are taking the drugs more often to manage obesity, researchers reported in the journal Diabetes, Obesity and Metabolism. The problem is that these ...
News Medical on MSN11d
Antibiotic exposure in infancy may boost Type 1 diabetes risk, reveals researchExposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin- producing cells in the ...
Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...
Community members gathered at the Locust Country Club Saturday evening for the annual Breakthrough T1D Gala, which raises ...
10d
FOX 26 Houston on MSNInhaled insulin offers hope for diabetes managementInhaled insulin has been available for about a decade, offering a rapid-acting alternative to traditional insulin shots.
10d
WTAP on MSNMarch Health Check Part 2: How Diabetes impacts the body’s major organs and how to treat itWest Virginia consistently ranks among the highest for diabetes prevalence in the nation not to mention the tens of thousands ...
In contrast, about 5.1 million adults with type 2 diabetes filled a prescription for one of these agents in 2022. This indicates that the total national expenditure on GLP-1 agents was "largely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results